Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$615M |
| 2 |
Uber
UBER
|
+$551M |
| 3 |
Expedia Group
EXPE
|
+$523M |
| 4 |
PayPal
PYPL
|
+$452M |
| 5 |
Eaton
ETN
|
+$408M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$681M |
| 2 |
RTN
Raytheon Company
RTN
|
+$543M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$537M |
| 4 |
Charter Communications
CHTR
|
+$472M |
| 5 |
SPDR Gold Trust
GLD
|
+$464M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.29% |
| 2 | Financials | 4.55% |
| 3 | Industrials | 4.18% |
| 4 | Healthcare | 4.08% |
| 5 | Consumer Discretionary | 3.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RARX
926
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $37.2M | 0.02% |
792,871
+681,925
| +615% | +$30.1M |
|
927
JPMorgan BetaBuilders Europe ETF
BBEU
$9.53B
| $37.2M | 0.02% |
725,985
+102,390
| +16% | +$5.01M |
|
|
KSU
928
DELISTED
Kansas City Southern
KSU
| $36.9M | 0.02% |
240,619
-712,201
| -75% | -$105M |
|
929
PUT
KraneShares CSI China Internet ETF
KWEB
$5.31B
| $36.9M | 0.02% |
757,000
+105,500
| +16% | +$4.82M |
|
930
PUT
Crown Castle
CCI
$31.5B
| $36.8M | 0.02% |
258,900
+2,000
| +0.8% | +$273K |
|
|
XLRN
931
DELISTED
Acceleron Pharma
XLRN
| $36.8M | 0.02% |
693,383
-92,290
| -12% | -$4.21M |
|
932
CALL
Deere & Co
DE
$165B
| $36.7M | 0.02% |
211,700
-409,600
| -66% | -$70.5M |
|
|
LK
933
DELISTED
Luckin Coffee Inc. American Depositary Shares
LK
| $36.6M | 0.02% |
929,250
+34,525
| +4% | +$873K |
|
934
CALL
iShares US Real Estate ETF
IYR
$4.58B
| $36.5M | 0.02% |
392,300
-177,800
| -31% | -$16.5M |
|
935
SolarEdge
SEDG
$1.98B
| $36.4M | 0.02% |
383,236
+205,002
| +115% | +$17.5M |
|
936
PUT
DuPont de Nemours
DD
$19.5B
| $36.3M | 0.02% |
450,834
-56,005
| -11% | -$4.65M |
|
937
SM Energy
SM
$7.71B
| $36.2M | 0.02% |
3,222,184
-759,489
| -19% | -$6.84M |
|
938
Franco-Nevada
FNV
$44.7B
| $36M | 0.02% |
348,986
-36,808
| -10% | -$3.56M |
|
939
Monolithic Power Systems
MPWR
$67B
| $35.9M | 0.02% |
201,833
+155,875
| +339% | +$24.9M |
|
940
Twilio
TWLO
$37.9B
| $35.9M | 0.02% |
365,267
+65,910
| +22% | +$6.73M |
|
|
SWTX
941
DELISTED
SpringWorks Therapeutics
SWTX
| $35.8M | 0.02% |
930,869
-392,948
| -30% | -$9.2M |
|
942
AXIS Capital
AXS
$7.26B
| $35.8M | 0.02% |
602,694
+472,087
| +361% | +$28.6M |
|
943
Zimmer Biomet
ZBH
$18.7B
| $35.8M | 0.02% |
246,350
-702,144
| -74% | -$96.9M |
|
|
COR
944
DELISTED
Coresite Realty Corporation
COR
| $35.6M | 0.02% |
317,535
-142,427
| -31% | -$16.5M |
|
|
RTN
945
CALL
DELISTED
Raytheon Company
RTN
| $35.6M | 0.02% |
162,000
+10,300
| +7% | +$2.18M |
|
946
PUT
Equinix
EQIX
$106B
| $35.5M | 0.02% |
60,800
-146,800
| -71% | -$82.5M |
|
947
Douglas Emmett
DEI
$1.99B
| $35.5M | 0.02% |
808,094
+682,989
| +546% | +$29.5M |
|
948
PUT
iShares MSCI Mexico ETF
EWW
$1.87B
| $35.4M | 0.02% |
787,200
+25,900
| +3% | +$1.15M |
|
949
XP
XP
$8.18B
| $35.4M | 0.02% |
+919,461
| New | +$34.5M |
|
950
CALL
Teva Pharmaceuticals
TEVA
$42.6B
| $35.3M | 0.02% |
3,602,400
-238,800
| -6% | -$2.13M |
|
Similar funds
Ken Griffin's Q4 2019 Portfolio in Review
As of Q4 2019, Ken Griffin held 10,299 positions worth $230B, up 8.7% from $212B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Ken Griffin withdrew a net $8.18B in Q4 2019, closing 1,266 positions and reducing 4,117 holdings. Its most notable exit was Celgene Corp, an estimated $681M position sold in full.
By sector, the portfolio is most concentrated in Technology at 5.3% of assets, down from 5.4% a quarter earlier, followed by Financials and Industrials.
Against the trend, Ken Griffin opened a new position in Interxion Holding N.V. worth $83.9M.
- Ken Griffin's largest Q4 2019 buy was Interxion Holding N.V.: 1,000,931 shares worth $83.9M.
- Ken Griffin added most to Amazon in Q4 2019, an estimated $615M increase.
- Ken Griffin's biggest Q4 2019 reduction was Raytheon Company, cutting an estimated $543M.
- Ken Griffin fully exited Celgene Corp in Q4 2019, selling an estimated $681M.
- Ken Griffin's ten largest holdings make up 23% of its $230B portfolio in Q4 2019.
- Ken Griffin opened 1,220 new positions and closed 1,266 in Q4 2019.
- Ken Griffin's portfolio value rose 8.7% quarter-over-quarter to $230B.
Based on Citadel Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.